Blood pressure control in diabetes: Are we achieving the guideline targets?

Practical Diabetes International

Volumn 20, Issue 8, 2003, Pages 276-282

  Joseph, Franklin ^a   Younis, Naveed ^a   Sowery, Julie ^a   Soran, Handrean ^a   Stanaway, Steve ^b   Bowen Jones, David ^a  

^a ARROWE PARK HOSPITAL   (United Kingdom)

^b Diabetes and Edocrinology   (United Kingdom)

Author keywords

Audit; Blood pressure; Diabetes; Hypertension; Prevalence

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONSULTATION; DIABETES MELLITUS; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG USE; FEMALE; GENERAL HOSPITAL; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED KINGDOM;

EID: 0142215988     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.531     Document Type: Article

References (16)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl 5): S1-85
2. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11: 309-317.
3. Ramsay L, Williams B, Johnston G, et al. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-592.
4. UK Prospective Diabetes Study. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Group. BMJ 1998; 317: 703-713.
5. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762
6. Sever PS. Simple blood pressure guidelines for primary health care. J Hum Hypertens 1999; 13: 725-727.
7. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
8. Ramsay LE, Wallis EJ, Yeo WW, Jackson PR. The rationale for differing national recommendations for the treatment of hypertension. Am J Hypertens 1998; 11: 79S-88S.
9. Viberti G, Mogensen CE, Groop L, Pauls J. Effects of captopril on progression to clinical proteinuria in patients with insulin-dependant diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-279.
10. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213-219.
11. Sawicki PT, Berger M. Pharmacological treatment of diabetic patients with cardiovascular complications. J Intern Med 1998; 243: 181-189
12. Masding MG, Jones JR, Bartley E, Sandeman DD. Assessment of blood pressure in patients with Type 2 diabetes: Comparison between home blood pressure monitoring, clinic blood pressure measurement and 24-h ambulatory blood pressure monitoring. Diabet Med 2001; 18: 431-437.
13. Myers MG. Ambulatory blood pressure monitoring: Guidelines for use in clinical practice. Can J Cardiol 1996; 12: 1271-1275.
14. Strachan MJW, Gough K, McKnight JA, Padfield PL. Ambulatory blood pressure monitoring: Is it necessary for the routine assessment of hypertension in people with diabetes. Diabetic Med 2002; 19: 787-789.
15. Munro N, Feher M, Lawrenson R. Twelve months post-UKPDS and HOT: Antihypertensive drug prescribing and achieved BP in type 2 diabetes. Br J Cardiol 2001; 8: 332-336.
16. Lasker SS, Chowdhury TA: A survey of hypertension treatment in patients with Type 2 diabetes treated in primary care. Diabetes Today 2001; 4: 122-125.